Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Gut microbiome discovery provides roadmap for life-saving cancer therapies

The balance between bacterial communities in the gut affects the likelihood of a positive response to drugs called checkpoint inhibitors.
  1. Giorgia Guglielmi

    1. Giorgia Guglielmi is a science journalist in Basel, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Despite their small size, gut bacteria wield large influence over the effectiveness of certain cancer drugs. Researchers have now found that the ratio of specific microbial communities in the gut can help to predict who will respond to next-generation drugs for treating some kinds of cancer1.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-024-02070-9

References

  1. Derosa, L. et al. Cell https://doi.org/10.1016/j.cell.2024.05.029 (2024).

    Article  Google Scholar 

  2. Gopalakrishnan, V. et al. Science 359, 97–103 (2018).

    Article  PubMed  Google Scholar 

  3. Routy, B. et al. Science 359, 91–97 (2018).

    Article  PubMed  Google Scholar 

  4. Matson, V. et al. Science 359, 104–108 (2018).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links